Volume 2, Number 1—January 1996
Dispatch
Unexplained Deaths Due to Possibly Infectious Causes in the United States: Defining the Problem and Designing Surveillance and Laboratory Approaches
Table 1
007.9 |
unspecified protozoal intestinal disease |
420.9 |
other and unspecified acute pericarditis |
785.6 |
enlargement of lymph nodes |
008.5 |
bacterial enteritis, unspecified |
421.0 |
acute and subacute bacterial endocarditis |
786.0 |
dyspnea and respiratory abnormalities |
008.8 |
intestinal infectious due to other organisms: other organism, not classified elsewhere |
421.9 |
acute endocarditis, unspecified |
792 |
nonspecific abnormal findings in other body substances |
009.0 |
infectious colitis, enteritis, and gastroenteritis |
422.9 |
other and unspecified myocarditis |
792.0 |
cerebrospinal fluid |
009.1 |
colitis, enteritis, and gastroenteritis of presumed infectious origin |
424.9 |
endocarditis, valve unspecified |
792.1 |
stool contents |
009.2 |
infectious diarrhea |
425.4 |
other primary cardiomyopathies |
792.2 |
semen |
009.3 |
diarrhea of presumed infectious origin |
425.9 |
secondary cardiomyopathy, unspecified |
792.3 |
amniotic fluid |
027.9 |
unspecified zoonotic bacterial disease |
446.6 |
thrombotic microangiopathy |
792.4 |
saliva |
038.9 |
unspecified septicemia |
465.0 |
acute laryngopharyngitis |
792.9 |
other nonspecific abnormal findings in body substances |
041.9 |
bacterial infection in conditions classified elsewhere and of unspecified site: bacterial infection, unspecified |
465.8 |
acute upper respiratory infections of multiple or unspecified sites: other multiple sites |
795 |
nonspecific abnormal histologic and immunologic findings |
046.9 |
unspecified slow virus infection of the central nervous system |
465.9 |
acute upper respiratory infections of multiple or unspecified sites: unspecified site |
795.3 |
nonspecific positive culture findings |
047.9 |
unspecified viral meningitis |
466.0 |
acute bronchitis |
795.4 |
other nonspecific abnormal histologic findings |
049.9 |
unspecified non-arthropodborne viral diseases of central nervous system |
466.1 |
acute bronchiolitis |
795.7 |
other nonspecific immunologic findings |
057.9 |
viral exanthem, unspecified |
480.9 |
viral pneumoma, unspecified |
796.4 |
other nonspecific abnormal findings: other abnormal clinical findings |
079.9 |
viral infection in conditions classified elsewhere and of unspecified site: unspecified viral and chlamydial infection |
482.9 |
bacterial pneumonia, unspecified |
798 |
sudden death, cause unknown |
099.0 |
venereal disease, unspecified |
485 |
bronchopneumonia, organism unspecified |
798.1 |
instantaneous death |
136.9 |
other and unspecified infectious and parasitic diseases: unspecified infectious and parasitic diseases |
486 |
pneumonia, organism unspecified |
798.2 |
death occurring in less than 24 hours from the onset of symptoms, not otherwise explained |
283.1 |
non-autoimmune hemolytic anemias |
511.9 |
unspecified pleural effusion |
798.9 |
unattended death |
284.8 |
other specified aplastic anemias |
518.4 |
acute edema of lung, unspecified |
799 |
other ill-defined and unknown causes of morbidity and mortality |
286.6 |
defibrination syndrome |
518.8 |
other diseases of lung |
799.0 |
asphyxia |
287.3 |
primary thrombocytopenia |
519.9 |
unspecified disease of respiratory system |
799.1 |
respiratory failure |
287.5 |
thrombocytopenia, unspecified |
558 |
other and unspecified noninfectious gastroenteritis and colitis |
799.3 |
debility, unspecified |
320.9 |
meningitis due to unspecified bacterium |
780.6 |
pyrexia of unknown origin |
799.4 |
cachexia |
322.9 |
meningitis, unspecified |
782.1 |
rash and other nonspecific skin eruption |
799.8 |
other ill-defined conditions |
323.9 |
unspecified cause of encephalitis |
782.7 |
spontaneous ecchymoses |
799.9 |
other unknown and unspecified cause |
357.0 | acute infective polyneuritis | 785.5 | shock without mention of trauma |
1The Unexplained Deaths Working Group: Grechen Rothrock, University of California at Berkeley; Duc Vugia, California Department of Health Services; James Hadler, Matt Cartter, Connecticut Department of Public Health and Addiction Services; James Meek, Robin Ryder, Mark Wilson, Yale University School of Medicine; Michael Osterholm, Kristine L. MacDonald, Jean Rainbow, Norman Crouch, Kathy LeDell, Minnesota Department of Health; David Fleming, Katrina Hedberg, Oregon Health Division; Don Brenner, Mark Eberhard, James Olson, Pierre Rollin, R. Gibson Parrish, CDC.
Page created: December 20, 2010
Page updated: December 20, 2010
Page reviewed: December 20, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.